Atlas Trials

Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens

Clinical trial NCT01854099 · WITHDRAWN

Trial details

NCT number
NCT01854099
Sponsor
University of Florida
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma
Start date
2014-01-01
Primary completion
2014-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.